The 21st Century Cures Act (H.R. 34) evolved over several years as Congress focused on ways to accelerate and improve the way therapies and cures are discovered, developed and delivered. With strong bi-partisan and stakeholder support, Cures became a movement, which culminated in passage of the comprehensive legislative package in the House and Senate on November 30 and December 7, 2016, respectively.
The legislation includes many provisions impacting the discovery, development and delivery of treatments and cures for disorders under MDA's umbrella and that impact access to services including:
The legislation will now go to President Obama to be signed into law.
The 21st Century Cures Act was developed during a year-long process in the Energy & Commerce Committee of the U.S. House of Representatives of listening to and engaging with the patient and therapy development community. The Committee held multiple hearings and conducted round table discussions to explore ways to accelerate the discovery, development and delivery of treatments and cures in the United States. An earlier version of the bill (H.R. 6) passed committee unanimously (vote 51-0) and overwhelming passed in the full House in July 2015 by a vote of 344-77. The final version of the bill (H.R. 34) resulted after many months of discussions between the House and Senate and serve as an example of collaboration among the parties and both chambers of Congress.